Skip to main content

Published locations for SURPASS-4: ‘Twincretin’ tirzepatide surpasses insulin glargine in pivotal trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. SURPASS-4: ‘Twincretin’ tirzepatide surpasses insulin glargine in pivotal trial

User login

  • Reset your password
  • /content/surpass-4-twincretin-tirzepatide-surpasses-insulin-glargine-pivotal-trial
  • /clinicianreviews/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin-glargine
  • /familypracticenews/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin
  • /internalmedicinenews/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin
  • /clinicalendocrinologynews/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin
  • /ecardiologynews/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin-glargine
  • /cardiology/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin-glargine
  • /endocrinology/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin-glargine
  • /internalmedicine/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin-glargine
  • /familymedicine/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin-glargine
  • /type-2-diabetes-icymi/article/247937/diabetes/surpass-4-twincretin-tirzepatide-surpasses-insulin